急性脑出血患者血清VILIP-1、sTREM-1水平变化及其与神经功能缺损程度和预后的关系  

Changes in serum VILIP-1 and sTREM-1 levels in patients with acute cerebral hemorrhage and their correlation with the degree of neurological deficit and prognosis

作　　者：金吉明[1] 吴艳杰[1] 闫世林[1] 李占增 柳洋 JIN Jiming;WU Yanjie;YAN Shilin;LI Zhanzeng;LIU Yang(Department of Emergency,Tangshan People′s Hospital,Tangshan,Hebei 063000,China)

机构地区：[1]唐山市人民医院急诊科,河北唐山063000

出　　处：《国际检验医学杂志》2024年第18期2223-2228,共6页International Journal of Laboratory Medicine

基　　金：河北省医学科学研究课题计划项目(20211030)。

摘　　要：目的探讨急性脑出血(ACH)患者血清视锥蛋白样蛋白-1(VILIP-1)、可溶性髓系细胞触发受体-1(sTREM-1)水平变化及其与神经功能缺损程度和预后的相关性。方法选取2021年1月至2023年1月该院收治的115例ACH患者为ACH组,另选取同期在该院体检的115例健康志愿者作为对照组。根据美国国立卫生研究院卒中量表(NIHSS)评估的神经功能缺损程度将ACH患者分为轻度缺损组(39例)、中度缺损组(46例)、重度缺损组(30例)。随访90 d,根据改良Rankin量表评估的预后将ACH患者分为预后不良组(27例)和预后良好组(88例)。采用酶联免疫吸附试验检测血清VILIP-1、sTREM-1水平。通过Spearman相关性分析ACH患者NIHSS评分与血清VILIP-1、sTREM-1水平的相关性,建立多因素Logistic回归模型分析影响ACH患者预后的因素,绘制受试者工作特征(ROC)曲线分析血清VILIP-1、sTREM-1水平对ACH患者预后不良的预测价值。结果与对照组相比,ACH组血清VILIP-1、sTREM-1水平升高(P<0.05)。轻度缺损组、中度缺损组、重度缺损组血清VILIP-1、sTREM-1水平依次升高(P<0.05)。Spearman相关性分析结果显示,ACH患者NIHSS评分与血清VILIP-1、sTREM-1水平呈正相关(r=0.792、0.781,均P<0.001)。随访90 d,115例ACH患者预后不良发生率为23.48%(27/115)。多因素Logistic回归分析显示,血肿体积增加和NIHSS评分、VILIP-1、sTREM-1升高为影响ACH患者预后的独立危险因素(P<0.05)。ROC曲线分析显示,血清VILIP-1、sTREM-1水平联合预测ACH患者预后不良的曲线下面积为0.872,大于血清VILIP-1、sTREM-1水平单独预测的0.784、0.772(P<0.05)。结论ACH患者血清VILIP-1、sTREM-1水平升高,与神经功能缺损程度加重和预后不良密切相关,血清VILIP-1、sTREM-1水平联合检测对ACH患者预后不良具有较高的预测价值。Objective To investigate the changes in the levels of serum visinin-like protein-1(VILIP-1)and soluble triggering receptor expressed on myeloid cells-1(sTREM-1)in patients with acute cerebral hemorrhage(ACH)and their correlation with the degree of neurological deficits and prognosis.Methods Totally 115 cases of ACH patients admitted to this hospital from January 2021 to January 2023 were selected as the ACH group,and another 115 healthy volunteers with physical examination in the same period were selected as the control group.The ACH patients were divided into mild deficit group(39 cases),moderate deficit group(46 cases)and severe deficit group(30 cases)according to the degree of neurological deficit assessed by the national institutes of health stroke scale(NIHSS).Patients with ACH were divided into a poor prognosis group(27 cases)and a good prognosis group(88 cases)after 90 d of follow-up according to the prognosis assessed by the modified Rankin scale.Serum VILIP-1 and sTREM-1 levels were measured by enzyme-linked immunosorbent assay.Spearman correlation was used to analyze the correlation between NIHSS scores and serum VILIP-1 and sTREM-1 levels in ACH patients,a multifactorial Logistic regression model was set up to analyze the factors affecting the prognosis of ACH patients,and the predictive value of serum VILIP-1 and sTREM-1 levels in poor prognosis in ACH patients was analyzed by plotting the receiver operating characteristic(ROC)curve.Results Compared with the control group,serum VILIP-1 and sTREM-1 levels were elevated in the ACH group(P<0.05).Serum VILIP-1 and sTREM-1 levels increased sequentially in the mild-deficiency,moderate-deficiency,and severe-deficiency groups(P<0.05).Spearman correlation analysis showed a positive correlation between NIHSS scores and serum VILIP-1 and sTREM-1 levels in ACH patients(r=0.792 and 0.781,both P<0.001).After 90 d of follow-up,the incidence of poor prognosis in 115 ACH patients was 23.48%(27/115).Multifactorial Logistic regression analysis showed that increased hema

关 键 词：急性脑出血 视锥蛋白样蛋白-1 可溶性髓系细胞触发受体-1 神经功能缺损 预后 

分 类 号：R446.1[医药卫生—诊断学] R743.34[医药卫生—临床医学]